ALLYSON LESLIE: Open Payments
NPI 1770297228 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 20 payments from 12 companies in 2025. Trend: 2023 $514 · 2024 $333 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| ABBVIE INC. | 3 | $48 |
| Edwards Lifesciences Corporation | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
Products named: Ozempic, VRAYLAR, SAPIEN 3 Ultra RESILIA, LEQVIO, JOURNAVX, NURTEC ODT, BREZTRI, ROTATEQ.
Industry payments across NV — which companies pay providers there.
